
Pupil Technology is a company that specializes in artificial intelligencemyopia prevention and controlA provider of healthcare solutions.
Company Overview
Background and Date of Establishment: Pupil Technology was founded in 2022, the exact month may vary depending on the subsidiary or place of incorporation. The company has rapidly emerged in the field of myopia prevention and control with its unique technological advantages and market insights.
Registered capital and shareholding structureThe registered capital of Jiangsu Pupil Technology Co., Ltd. is 10,416,700 yuan, and the major shareholder is Zhejiang Ouolangvision Technology Co., Ltd. with 48% shares, while Zhejiang Ouolangvision Technology Co., Ltd. is held by Su Zhenyu with 40% shares. such a shareholding structure provides stable financial support and strategic guidance for the development of the company.
Legal representatives and key personnelLtd. is legally represented by Su Zhenyu, who has extensive experience and deep expertise in the field of myopia prevention and control. In addition, the company has a core team of industry experts and senior technicians, which provides a strong talent guarantee for the company's development.
Financing
Pupil Technology has recently completed a 10 million dollar angel round of financing, which was invested by Suzhou Jiahong Medical Fund. The funds received will be used to support further product development and production. This round of financing not only reflects the capital market's recognition of Pupil Technology's technical strength and market prospects, but also provides strong financial support for the company's future development.
Products & Services
The core product of Pupil Technology is the "OUO AI Cloud Vision System", which is a cloud-based myopia prevention and control medical system consisting of three major parts: fully automated optometry testing medical equipment, cloud-based AI diagnostic/prediction model, and OUO AI vision trainer. The system is mainly targeted at young people aged 6 to 18, and can help prevent pseudomyopia, control the process of true myopia, and significantly reduce the subsequent expenditure on myopia correction from the root.
-
Fully automated medical devices for optometric testing: The device is capable of automatic tracking, focusing and measurement, and combined with a cloud-based diagnostic system based on more than 20 myopia prevention and control indicators such as eye axis, refraction, corneal curvature, etc., it only takes more than 10 seconds to complete an optometric examination and issue a high-precision analysis report.
-
Cloud-based AI diagnostic/predictive modelingThe system is able to predict the myopia development trend of users and provide personalized intervention plans based on the "electronic vision file" generated by IoT technology and the learning and analysis of myopia data by the cloud prediction model. Pre-test results show that the prediction accuracy exceeds 90%.
-
OUO AI Vision Trainer: The product has been iterated to the sixth generation, which helps to slow down the development of myopia and eliminate pseudomyopia by utilizing a complete set of optical system based on ciliary muscle potential training, dynamic defocus control, and dynamic foggy vision, among other designs. Its focus control precision can reach 150 nanometers, much higher than the adjustment precision of general technology.
Market layout and business model
Pupil Technology is mainly oriented to the school and C-end market. At present, the company has reached cooperation with thousands of schools on the system hardware and software procurement, but also for the C-end market at the same time laying the online and offline channels, so far laying more than 100 offline stores. In terms of customer acquisition, Pupil Technology has launched a "rental experience" model, which allows customers to rent the Ou Ou AI eye care device for one month without deposit, and then decide whether to renew the device depending on the experience and effect of use. This model helps to expand the "seed users", the formation of word of mouth effect.
future outlook
Pupil Technology plans to build a more diversified product layout around "myopia prevention and control". As parents become more aware of myopia prevention and control, this market is expected to develop into a blue ocean. In the future, Pupil Technology will continue to improve the existing products, and for youth myopia control, correction and gradually incorporate other products, such as out-of-focus glasses, OK lenses, low-concentration atropine, etc., in order to achieve the effect of "1 + 1 > 2".
In summary, with its advanced technical strength, rich product line and broad market prospect, Pupil Technology has shown strong competitiveness and development potential in the field of artificial intelligence myopia prevention and control.
data statistics
Relevant Navigation

A high-tech enterprise focusing on AI healthcare, dedicated to improving global life health through artificial intelligence technology and providing advanced intelligent medical integration services.

Ping An Technology
It focuses on using AI technology to provide intelligent solutions for finance, healthcare, smart cities and other fields, and promotes industry progress and upgrading through technological innovation.

Guoxin Healthcare
The company is a state-owned health guarantee service enterprise mainly engaged in comprehensive management service of medical insurance, and is committed to building China's health guarantee service system and providing technical guarantee service for the national strategy of "Healthy China" in the new era.

Jintai Technology
A leading company utilizing artificial intelligence and robotics to provide innovative R&D solutions for the global biomedical, chemical, and new energy industries.

Chengdu Pilot
A biotechnology company specializing in new drug discovery and providing innovative drug solutions using core technologies such as DNA-encoded compound libraries.

Yidu Tech
A company specializing in healthcare big data solutions, providing comprehensive support for medical research, healthcare management, regional public health and population health management, and innovative drug development through big data and artificial intelligence technologies.

Fosun Almond Pulse
Focusing on the research, development and application of medical imaging artificial intelligence technology, we are committed to improving the efficiency and accuracy of medical imaging diagnosis.

Lingyi Zhihui
Driven by Baidu's brain technology, the AI healthcare brand, with the vision of "Empowering Primary Healthcare with Evidence-Based AI", provides a full range of healthcare solutions such as clinical assisted decision-making, fundus image analysis, and healthcare big data, to serve the primary healthcare and help improve the quality of healthcare.
No comments...